HMOX1 and metabolic dysfunction-associated steatohepatitis: Activated AMPK also boosts Nrf2/HO-1 signaling and suppresses mTOR pathways, promoting autophagy and mitochondrial biogenesis, which helps improve NASH (Figure 3) [61,62].